Overview
Auri P. Garcia Gonzalez, MD PhD is a General Surgery Resident at Duke University. Dr. Garcia Gonzalez began her residency at Duke in 2021, which included a Post-Doctoral Research Fellowship in the laboratory of Dr. Lawrence David in the Duke Microbiome Center under the Department of Molecular Genetics and Microbiology. Her clinical interests include colorectal surgery, robotic surgery and acute care surgery. Her research focus in the David lab has been to use a mouse model of fecal diversion to understand host-microbe interactions during low nutrient conditions. Her ultimate goal is to develop microbiome-targeting therapeutics for patients with fecal diversion, or with intestinal starvation.
Dr. Garcia Gonzalez was born and raised in San Juan, Puerto Rico. She graduated the University of Puerto Rico with a degree in Cellular and Molecular Biology and Mathematics, where she graduated Summa Cum Laude. She then moved to the University of Massachusetts for her MD/PhD. Her graduate degree is in Systems Biology; she studied host-microbe-drug interactions in the laboratory of Dr. Marian Walhout.
Dr. Garcia Gonzalez was born and raised in San Juan, Puerto Rico. She graduated the University of Puerto Rico with a degree in Cellular and Molecular Biology and Mathematics, where she graduated Summa Cum Laude. She then moved to the University of Massachusetts for her MD/PhD. Her graduate degree is in Systems Biology; she studied host-microbe-drug interactions in the laboratory of Dr. Marian Walhout.
Recent Publications
Management of neuroendocrine tumors of the rectum
Journal Article Seminars in Colon and Rectal Surgery · September 1, 2022 Rectal neuroendocrine tumors (NETs) have increased in prevalence due to increased detection via endoscopic screening for colorectal neoplasia, advances and availability of imaging tools along with the indolent nature of the tumor. Imaging techniques to ide ... Full text CiteBacterial diet modulates tamoxifen-induced death via host fatty acid metabolism.
Journal Article Nature communications · September 2022 Tamoxifen is a selective estrogen receptor (ER) modulator that is used to treat ER-positive breast cancer, but that at high doses kills both ER-positive and ER-negative breast cancer cells. We recapitulate this off-target effect in Caenorhabditis elegans, ... Full text CiteWormPaths: Caenorhabditis elegans metabolic pathway annotation and visualization.
Journal Article Genetics · August 2021 In our group, we aim to understand metabolism in the nematode Caenorhabditis elegans and its relationships with gene expression, physiology, and the response to therapeutic drugs. Visualization of the metabolic pathways that comprise the metabolic network ... Full text CiteRecent Grants
Fecal diversion as a model for host-microbe interactions.
ResearchPrincipal Investigator · Awarded by Burroughs Wellcome Fund · 2024 - 2027View All Grants